Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in...

Cancer Chemotherapy and Pharmacology 2016 / 9 Vol. 78; Iss. 3

Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients

Madan, Ankit, Jones, Benjamin S., Bordoni, Rodolfo, Saleh, Mansoor N., Jerome, Mary S., Miley, Deborah K., Jackson, Bradford E., Robert, Francisco
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
78
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-3088-5
Date:
September, 2016
File:
PDF, 469 KB
english, 2016
Conversion to is in progress
Conversion to is failed